MENU
+Compare
BCS
Stock ticker: NYSE
AS OF
Jun 30 closing price
Price
$18.59
Change
+$0.26 (+1.42%)
Capitalization
34.89B

BCS Barclays PLC Forecast, Technical & Fundamental Analysis

Barclays is a universal bank headquartered in the United Kingdom... Show more

Industry: #Major Banks
BCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BCS with price predictions
Jun 30, 2025

BCS in upward trend: price may jump up because it broke its lower Bollinger Band on June 13, 2025

BCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where BCS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on BCS as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BCS just turned positive on June 27, 2025. Looking at past instances where BCS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BCS advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 327 cases where BCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BCS moved out of overbought territory on June 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 31, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.390) is normal, around the industry mean (0.958). P/E Ratio (6.839) is within average values for comparable stocks, (8.937). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (2.643). Dividend Yield (0.037) settles around the average of (0.053) among similar stocks. P/S Ratio (1.152) is also within normal values, averaging (2.460).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
BCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BCS is expected to report earnings to fall 16.79% to 57 cents per share on July 29

Barclays PLC BCS Stock Earnings Reports
Q2'25
Est.
$0.58
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.40
Q3'24
Missed
by $0.32
Q2'24
Missed
by $0.27
The last earnings report on April 30 showed earnings per share of 69 cents, beating the estimate of 67 cents. With 13.83M shares outstanding, the current market capitalization sits at 34.89B.
A.I.Advisor
published Dividends

BCS paid dividends on April 04, 2025

Barclays PLC BCS Stock Dividends
А dividend of $0.27 per share was paid with a record date of April 04, 2025, and an ex-dividend date of February 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

a major banks

Industry MajorBanks

Profile
Fundamentals
Details
Industry
Major Banks
Address
1 Churchill Place
Phone
+44 2071163170
Employees
92400
Web
https://www.barclays.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALHC14.000.15
+1.08%
Alignment Healthcare
OSIS224.860.81
+0.36%
OSI Systems
NVR7385.6610.15
+0.14%
NVR
CRDF3.15N/A
N/A
Cardiff Oncology
RLMD0.60-0.07
-10.82%
Relmada Therapeutics

BCS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCS has been closely correlated with HSBC. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCS jumps, then HSBC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCS
1D Price
Change %
BCS100%
+1.42%
HSBC - BCS
70%
Closely correlated
-0.05%
NWG - BCS
69%
Closely correlated
+0.71%
C - BCS
67%
Closely correlated
+0.88%
WFC - BCS
66%
Loosely correlated
+0.78%
SAN - BCS
65%
Loosely correlated
+0.73%
More

Groups containing BCS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCS
1D Price
Change %
BCS100%
+1.42%
BCS
(5 stocks)
80%
Closely correlated
+0.75%